As a leading company in personalized medicine, GreenMCMeds is proud to introduce the first Comprehensive Cancer Risk Assessment test designed to determine the risk of developing up to 8 cancer types. This non-invasive test helps the patient and clinician determine the level of risk for some of the most common solid tumor cancers including
Breast, Ovarian, Endometrial, Pancreas, Prostate, Skin, Stomach and ColoRectal Cancers. GreenMCMeds can help determine the level of risk of developing one or more of these 8 prevalent cancers.
As a leading company in preventative medicine, we assist the patient in the screening, diagnosis, and classification of cancer.
GreenMCMeds provides the highest quality molecular testing services to medical practitioners. Our highly experienced pathologists and molecular geneticists are leaders in their field with specialist knowledge and expertise. They provide informed and practical advice to assist with the interpretation of results.
Our highly experienced pathologists are members of hospital boards and health policy committees and provide a renowned and comprehensive service to thousands of patients each year reaching private and public hospital beds, specialists and general practitioners throughout United States and worldwide.
Doctors face an ever-expanding variety of genetic tests that could influence how they care for patients. Since the Human Genome Project was completed in 2003, the introduction of new genetic tests has far outpaced the ability of health practitioners. GreenMCMeds translates scientific discoveries into customized and more effective treatments for patients. We can help to predict cancer risk and determine how patients might respond to certain treatments.
Breast cancer is the most common female cancer, affecting approximately 1 in 8 women in the United States. Approximately 5-10% of breast cancers are hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation. Women who have an abnormal mutation can have up to an 87% risk of being diagnosed with breast cancer during their lifetimes.
Ovarian cancer is the ninth most common cancer in women, but it ranks fifth as the cause of cancer death in women. While most ovarian cancer does not run in the family, approximately 10-15% of ovarian cancer is hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation. Women who have an abnormal can have up to a 44% risk of being diagnosed with breast cancer during their lifetimes.
Colorectal cancer is cancer that starts in either the colon or the rectum. Most colorectal cancer does not run in the family, but approximately 5% of colorectal cancer is hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation.
Approximately 1 in 76 people will develop pancreatic cancer in their lifetime. Most pancreatic cancer develops by chance and does not run in families. However, some pancreatic cancers are hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation and cause up to 10% of Pancreatic Cancers
Endometrial cancer (cancer of the lining of the uterus) is the most common cancer of the female reproductive organs. Approximately 1 in 41 women will develop endometrial cancer. While most endometrial cancer does not run in the family, 1-5% of endometrial cancer is hereditary.
Gastric cancer (also called stomach cancer) is cancer that starts in the stomach. Most stomach cancers do not run in the family, but some stomach cancers are hereditary and gene abnormalities can significantly increase the risk of one or more types of gastric cancers.
Skin cancer is often divided into two categories: non-melanoma and melanoma. Non-melanoma skin cancers are the most common cancers in men and women. There are two types of non-melanoma skin cancer: basal cell carcinoma and squamous cell carcinoma.
Other than skin cancer, prostate cancer is the most common type of cancer found in American men. Prostate cancer is the second leading cause of death in men. Most cases of prostate cancer develop by chance and do not run in families. However, a portion of prostate cancers are hereditary. Hereditary cancers are caused by a mutation in a gene that can be passed on from generation to generation. Men who have an abnormal gene are as much as 20 times more likely to develop prostate cancer.
Genetic testing for cancer is predictive testing, which means a test that can help predict the likelihood that a patient will develop cancer in his or her lifetime. Not everyone with a cancer-related gene will develop cancer.
The good news is there is something that can be done about it! Patients at a higher risk for cancer may have the option of having more frequent cancer screenings, avoiding specific risk factors, making lifestyle changes to lessen additional risk, taking preventive medication (chemoprevention) or having risk reducing surgeries in order to reduce their risk of developing cancer.
DISCLAIMER: GreenMCMeds does not partake in cultivation or dispensing of cannabis in no way, shape, or form, nor are we affiliated with any dispensaries or cultivation sites.